Knobbe/Martens: Intellectual Property Law

Medical

Subscribe to Medical Blog

Medical Device Connectivity Market Reported to Top $2.6 Billion by 2023

June 15, 2018 Tom Cowan

The market for medical device connectivity is projected to reach about $2.6 billion by the year 2023, according to a report published in April 2018 by several publishers.  The report states that the connectivity market for 2018 is expected to be about $940 million.  This equates to a compound annual growth rate (CAGR) from 2018 to 2023 of 23.2%

First Prosthetic Iris Approved

June 12, 2018 Robert J. Hilton, Ph.D.

On May 30, 2018, the Food and Drug Administration announced the approval of the CustomFlex Artificial Iris. According to the FDA, this is the first approved artificial iris. The approval was granted to Clinical Research Consultants, Inc., and the device is marketed and developed by HumanOptics AG.

Cyberdyne Bringing HAL Cyborg Exoskeleton to US Market

Cyberdyne, a Japan-based robotics technology company, recently announced its collaboration with Brooks Rehabilitation and the Brooks Cybernic Treatment Center to bring its Hybrid Assistive Limb (HAL®) exoskeleton to the U.S. market.
 

Teleflex to Acquire QT Vascular’s Coronary Products for Nearly $100 Million

June 8, 2018 Sabrina Wang

According to the Straits TimesQT Vascular, a Singapore-based medical device company, reached an asset purchase and option agreement to sell its intellectual property rights to some of its non-drug coated coronary products, such as its Chocolate XD® and Glider™, to Teleflex Life Sciences Unlimited Company and Teleflex Incorporated (“Teleflex“). 

First Thrombectomy Device Cleared for Pulmonary Embolisms

June 8, 2018 Brandon G. Smith

The FDA announced 510(k) clearance for Inari Medical’s FlowTriever device for the treatment of pulmonary embolism (“PE”).  According to Inari, the FlowTriever system is the first thrombectomy device cleared for the treatment of PE.  The FlowTriever had previously been cleared for treatment of the peripheral vasculature.

Home / Blog DePuy Synthes Acquires Medical Enterprises Distribution LLC’s Orthopedic Assets

DePuy Synthes, a part of the Johnson & Johnson Medical Devices Companies, announced recently that it has signed a definitive agreement to acquire the assets of Medical Enterprises Distribution, LLC, which includes the automated ME1000™ Surgical Impactor tool used in hip replacement surgery.  The two companies had previously formed an exclusive agreement to co-market the hip application of the ME1000™. 

Alere Settles False Claims Act Allegations for $33 Million

May 8, 2018 Albert J. Sueiras

The United States Department of Justice announced in a press release that Alere Inc. and its subsidiary, Alere San Diego, reached a settlement agreement with the United States government for $33.2 million over allegations that Alere had violated the False Claims Act.  According to Healthcare Finance, the settlement did not include any admission of actual liability on Alere’s part.

Apple Releases Electronic Health Record Aggregation Tool in iOS 11.3

April 30, 2018 Scott R. Seeley

According to an Apple press release, iPhone users will now be able to store and view their medical records on their phones as part of a new feature found in iOS 11.3.  Although

China FDA Issues Guidance on 3D Printed Medical Devices

April 27, 2018 Bryan J. Johnson

More than two and a half years after the China Food and Drug Administration (CFDA) formally approved its first three-dimensional (3D) printed medical device for mass production, a hip implant co-developed by Peking University’s Third Hospital and AK Medical, the agency has issued a draft guidance on the regulatory requirements for approval of 3D printed devices.

Pages

Attorney Finder